Why the study?
As a dimensionless ratio, the left ventricular global function index has serious limitations requiring mathematical and clinical evaluation.
Does the companion metric of Left Ventricular Global Function Index (LVGFIC) provide incremental value over standard metrics in characterizing patients with acute myocarditis, takotsubo cardiomyopathy, and acute myocardial infarction?
Does the companion metric of Left Ventricular Global Function Index (LVGFIC) provide incremental value over standard metrics in characterizing patients with acute myocarditis, takotsubo cardiomyopathy, and acute myocardial infarction?
The companion metric to the Left Ventricular Global Function Index (LVGFIC) provides incremental value over standard imaging metrics like EF and GLS in characterizing specific cardiomyopathies and identifying sex-specific differences.
LVGFI limitations warrant clinical caution; leaves open its utility pending larger validation studies.
Left ventricular (LV) global function index (LVGFI) has been introduced as a volume-based composite metric for evaluation of ventricular function. The definition formula combines stroke volume (SV), end-systolic volume (ESV), end-diastolic volume (EDV) and LV mass/density. Being a dimensionless ratio, this new metric has serious limitations which require evaluation at a mathematical and clinical level. Using CMRI in 96 patients we studied LV volumes, various derived metrics and global longitudinal strain (GLS) in order to further characterize LVGFI in three diagnostic groups: acute myocarditis, takotsubo cardiomyopathy and acute myocardial infarction. We also considered the LVGFI companion (C), derived from the quadratic mean. Additional metrics such as ejection fraction (EF), myocardial contraction fraction (MCF) and ventriculo-arterial coupling (VAC), along with their companions (MCFC and VACC) were calculated. All companion metrics (EFC, LVGFIC, MCFC, and VACC) showed sex-specific differences, not clearly reflected by the corresponding ratio-based metrics. LVGFI is mathematically coupled to both EF (with R = 0.86) and VAC (R = 0.87), which observation clarifies why these metrics not only share similar prognostic values but also identical shortcomings. We found that the newly introduced LVGFIC has incremental value compared to the single use of LVGFI, EF, or GLS, when characterizing the three patient groups.
No takes yet. Share an insight, caveat, or question.
Díaz‐Navarro et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: